20-F: Meiwu Shifts to Skincare, Bitcoin Amidst Losses

Sentiment:

Annual Report


Meiwu Technology Company Limited reports a significant net loss in 2025, driven by a strategic pivot to functional skincare and a new Bitcoin treasury strategy, following the termination of its former VIE structure and legacy businesses.

Delay expectedThe comprehensive online ecosystem for functional skincare products, originally scheduled to launch in the fourth quarter of 2025, has been rescheduled to the third quarter of 2026 to integrate a proposed AI-driven functional skincare system.
Capital raiseOn May 17, 2024, the company issued convertible notes with gross proceeds of $1,000,000.On December 2, 2024, the company closed a best-efforts offering of 30,000,000 Ordinary Shares at $0.80 per share, receiving net proceeds of $23,895,000.On September 5, 2025, Mr. Changbin Xia purchased 12,000,000 restricted Ordinary Shares at $0.80 per share in a private placement.On January 26, 2026, the company entered into a securities purchase agreement for a best-efforts offering of 38,000,000 Ordinary Shares at $0.80 per share, receiving net proceeds of $30,224,051.On March 18, 2026, the company entered into a securities purchase agreement for 6,999,996 Ordinary Shares and warrants, with net proceeds of $12,651,733.
Worse than expectedThe company reported a net loss of $18,192,303 in 2025, a significant decline from a net income of $5,114,684 in 2024.Total assets decreased from $60,945,135 in 2024 to $50,733,945 in 2025.Cash and cash equivalents decreased from $43,396,977 in 2024 to $17,884,684 in 2025.The gross margin for the primary revenue driver, functional skincare products, was only 8.0% in 2025, significantly lower than the overall gross margin of 42.4% in 2024 (which included higher-margin legacy businesses).Assets impairment loss increased substantially to $9,834,584 in 2025, indicating significant write-downs related to previous business ventures.

Summary

  • Meiwu Technology Company Limited, a British Virgin Islands holding company, reported a net loss of $18,192,303 for the fiscal year ended December 31, 2025, a significant decline from a net income of $5,114,684 in 2024.
  • Total revenue increased to $7,081,133 in 2025 from $158,485 in 2024, primarily due to the new functional skincare business, which accounted for 97.7% of total revenue.
  • The company terminated its Variable Interest Entity (VIE) corporate structure in China on December 10, 2024, due to sustained losses from the former VIE's operations, shifting its focus to the functional skincare business.
  • A new Bitcoin treasury strategy was announced, intending to allocate approximately 50% of the net proceeds from the 2026 Primary Offering to acquire Bitcoin over time, with holdings not expected to exceed 30% of total treasury assets without board approval.
  • The company effectuated a one-for-twenty reverse stock split on April 1, 2025, and a one-for-one hundred reverse stock split on March 17, 2026.
  • Research and development expenses surged to $2,685,201 in 2025 from $689 in 2024, reflecting investment in new functional skincare products.
  • Assets impairment loss increased to $9,834,584 in 2025 from $1,449,371 in 2024, mainly due to impairment provisions for other receivables, advances to suppliers, and intangible assets related to former businesses.
  • The company completed a Primary Public Offering in December 2024, raising net proceeds of $23,895,000, and another in January 2026, raising net proceeds of $30,224,051, with funds earmarked for skincare business development and Bitcoin acquisition.
  • Management identified a material weakness in internal control over financial reporting as of December 31, 2025, due to a lack of in-house accounting personnel with sufficient US GAAP and SEC reporting experience.
  • The company plans to expand its marketing, branding, and distribution network for functional skincare, including establishing a network of approximately 1,500 affiliate stores.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing with caution due to significant net losses, high impairment charges, and a low gross margin in the new core business, despite strategic pivots and capital raises. The Bitcoin treasury strategy introduces additional volatility and regulatory risks.

Positives

  • Significant revenue growth in the new functional skincare business, reaching $6,919,620 in 2025, up from $60,227 in 2024.
  • Successful capital raises in 2024 ($23.9 million net proceeds) and 2026 ($30.2 million net proceeds) to fund strategic initiatives.
  • Strategic pivot to functional skincare and Bitcoin treasury allocation demonstrates adaptability and pursuit of new growth avenues.
  • Increased investment in research and development for functional skincare products, including cooperation agreements with research institutions and acquisition of patents.
  • Development of a comprehensive quality control framework for the functional skincare business, covering supply chain, warehousing, channel oversight, and after-sales support.
  • Launch of training services for store owners and distributors to enhance marketing and sales capabilities for skincare products.
  • The company's auditor, Enrome LLP, is headquartered in Singapore and subject to PCAOB inspection, reducing HFCAA delisting risk for now.

Negatives

  • Reported a substantial net loss of $18,192,303 in 2025, a significant deterioration from net income in 2024.
  • Gross profit margin for functional skincare products was low at 8.0% in 2025, indicating initial price-cutting strategies or high costs.
  • Significant increase in operating expenses, particularly sales and marketing (3091% increase) and general and administrative (88% increase) in 2025.
  • Large assets impairment loss of $9,834,584 in 2025, primarily from other receivables, advances to suppliers, and intangible assets related to discontinued businesses.
  • Termination of the VIE structure and disposal of former subsidiaries (Magnum, Xinfuxin) in 2024 resulted in a gain on disposal, but signifies the failure of previous business lines.
  • Material weakness identified in internal control over financial reporting due to lack of in-house US GAAP and SEC reporting expertise.
  • Cash and cash equivalents decreased significantly from $43,396,977 in 2024 to $17,884,684 in 2025.
  • The SMS business was suspended in December 2023 and generated no revenue in 2024, indicating a complete failure of that segment.

Risks

  • Operating in a dynamic functional skincare industry with a limited operating history, making future performance uncertain.
  • Reliance on third-parties for product formulas, potentially leading to adverse effects if agreements fail or competitors introduce similar products at lower prices.
  • Intense competition in the beauty industry from large multinational and domestic players with greater resources and brand recognition.
  • Dependence on product popularity and ability to anticipate and respond to rapidly changing industry trends and consumer preferences.
  • New product introductions may not be as successful as anticipated, impacting business, prospects, financial condition, and results of operations.
  • Business success is dependent on the quality, effectiveness, and safety of products; any issues could tarnish brand image and lead to recalls or liability claims.
  • Inability to successfully implement growth strategy, including building brand, penetrating markets, developing new products, and managing third-party partners.
  • Failure to provide superior customer experiences could materially and adversely affect business and reputation.
  • Reliance on distributors, retailers, and other third-parties could affect efficient and profitable distribution and marketing.
  • Subject to complex and evolving product safety laws, regulations, and standards, with potential for penalties and product liability claims for non-compliance.
  • Operating results could be materially harmed by inability to accurately forecast consumer demand or adequately manage inventory, leading to obsolescence or increased costs.
  • Reliance on third-party logistics services, with risks of disruption, termination, or failure to provide reliable services.
  • Delivery, return, and exchange policies may adversely affect results of operations if misused or if rates increase significantly.
  • Failure to successfully lease suitable warehouse facilities or any interruption in warehouse operations could negatively affect business.
  • Subject to infringement claims of intellectual property rights or other rights of third parties, which may be expensive to defend and disrupt business.
  • Inability to protect intellectual property could diminish brand value and adversely affect business.
  • Risk of fraud or other misconduct by employees or third-party partners, leading to business disruption, reputational harm, and regulatory penalties.
  • Failure to obtain and maintain requisite licenses, permits, registrations, and filings, or to obtain additional ones due to new regulations or business expansion.
  • Inability to offer branded products at attractive prices or maintain a reputation for authentic, high-quality products could lead to customer loss.
  • Future results and competitive position depend on successful development of new product offerings and improvement of existing products, which is inherently uncertain.
  • Inability to manage growth in current operations could disrupt operations and prevent expected revenue generation.
  • Acquisition growth strategy may not be successful, or integration challenges could negatively impact business.
  • Failure of products to comply with government safety requirements may adversely affect results.
  • Subject to payment processing risk, including increases in fees or changes in the payment ecosystem.
  • Security breaches and cyberattacks against internal systems and network, or failure to protect confidential information, could damage reputation and negatively impact business.
  • Revenue and net income may be materially and adversely affected by economic slowdown in China and trade disputes.
  • Supply network and supplier facilities could be disrupted by factors beyond control, such as extreme weather or natural disasters.
  • Higher labor costs could adversely affect business and financial results if not passed on to customers.
  • Bitcoin treasury strategy exposes the company to various risks associated with Bitcoin, including volatility, lack of interest/dividends, and untested strategy.
  • Risks relating to the custody of Bitcoin, including loss or destruction of private keys and cyberattacks.
  • Bitcoin and other digital assets are novel and subject to significant legal, commercial, regulatory, and technical uncertainty, including potential reclassification as a security.
  • Availability of spot Bitcoin ETPs may adversely affect the market price of the company's Ordinary Shares.
  • Bitcoin treasury strategy subjects the company to enhanced regulatory oversight, including anti-money laundering and sanctions laws.
  • Unregulated nature and lack of transparency of many Bitcoin trading venues may lead to greater fraud, security failures, or operational problems.
  • Emergence or growth of other digital assets could negatively impact Bitcoin price.
  • Bitcoin holdings are less liquid than cash and cash equivalents and may not serve as a source of liquidity.
  • Risk that custodially-held Bitcoin may become part of the custodian's insolvency estate.
  • Temporary or permanent blockchain fork to Bitcoin could adversely affect business.
  • Regulatory actions in one or more countries could severely affect the right to acquire, own, hold, sell, or use Bitcoin.
  • Regulatory environment regarding digital assets and mining is in flux, potentially limiting operations.
  • Uncertainties regarding the interpretation and enforcement of PRC laws, rules, and regulations.
  • Additional compliance procedures may be required for subsequent securities offerings due to new PRC filing rules.
  • Securities may be prohibited from trading in the United States under the HFCAA if PCAOB is unable to inspect auditors.
  • Actions by Chinese government to intervene or influence operations or exert control over overseas offerings could significantly limit or hinder ability to offer securities.
  • Greater oversight by the Cyberspace Administration of China (CAC) over data security could adversely impact business.
  • Reliance on dividends and other distributions from PRC subsidiaries, with limitations on their ability to make payments.
  • Fluctuations in exchange rates could have a material adverse effect on results of operations and share price.
  • PRC regulations relating to offshore investment activities by PRC residents may limit ability to increase registered capital or distribute profits.
  • Classification as a PRC resident enterprise for tax purposes could result in unfavorable tax consequences.
  • Incurrence of additional costs as a result of being a public company, negatively impacting net income and liquidity.
  • Obligation to disclose information publicly may put the company at a disadvantage to private competitors.
  • Disclosure obligations differ as a foreign private issuer, potentially making it more difficult for investors to evaluate performance.
  • Increased costs as a result of no longer qualifying as an emerging growth company.
  • Volatility in the trading price of Ordinary Shares due to various factors beyond control.
  • Requirement to comply with economic substance requirements in the British Virgin Islands, potentially leading to additional costs or penalties.

Future Outlook

The company intends to profitably grow its business through strategic initiatives, including seeking additional acquisition opportunities in food products (despite the pivot to skincare). It expects continued consumer demand for its products, future growth opportunities, and market share expansion. The company plans to further develop its functional skincare business, specifically expanding its marketing, branding, and distribution network, and acquiring Bitcoin as part of its treasury asset allocation. It also aims to allocate a portion of proceeds to strategic acquisitions, including a potential downstream channel distributor.

Management Comments

  • "Our intent is to profitably grow our business through our strategic initiatives."
  • "We intend to seek additional acquisition opportunities in food products and our expectation regarding competition for acquisitions."
  • "We believe bitcoin, due to its limited supply, has the potential to serve as a hedge against inflation in the long term."
  • "We intend to store all of the bitcoin we acquire in custody accounts with a third-party custodian located in the United States."
  • "We expect to hedge approximately 50% of our bitcoin holdings from time to time using bitcoin futures contracts."
  • "The Company intends to disclose its bitcoin holdings and related cost basis in accordance with applicable SEC disclosure requirements."
  • "The Investment Committee will be responsible for closely monitoring the Company's bitcoin investment strategy, including purchases, hedging, and risk management practices."
  • "Our Board will be involved for decisions of high significance, such as major changes to the bitcoin investment strategy, significant acquisitions, or shifts in our risk management framework."
  • "We believe that this will help ensure a balanced consensus among committee members for key decisions, while maintaining the efficiency needed for timely execution."
  • "We do not expect to incur materially greater costs as a result of becoming a public company than those incurred by similarly sized U.S. public companies."
  • "We believe that we maintain a good working relationship with our employees and to date, we have not experienced any significant labor disputes."

Industry Context

StockSavvy.ai notes that Meiwu's pivot to functional skincare aligns with a rapidly growing market in China, projected to achieve a 5% CAGR over the next five years and exceeding RMB 48 billion (USD 6.6 billion) in 2024. This shift capitalizes on evolving consumer preferences for ingredient transparency and product efficacy. The company's entry into beauty training services also taps into a growing demand for skilled professionals in China's expanding light medical aesthetics market. The adoption of a Bitcoin treasury strategy, while novel for an operating company, reflects a broader trend among some corporations to diversify cash holdings into digital assets, though it introduces significant volatility and regulatory risks inherent to the nascent crypto industry. The termination of the VIE structure and legacy food e-commerce and SMS businesses indicates a decisive move away from underperforming segments, a common strategy for companies seeking to streamline operations and focus on core competencies in competitive markets.

Comparison to Industry Standards

  • The functional skincare industry in China is projected to achieve a compound annual growth rate (CAGR) of approximately 5% over the next five years, with its market size exceeding RMB 48 billion (approximately USD 6.6 billion) in 2024, reflecting a five-year CAGR of 25.25%. Meiwu's entry into this market positions it within a high-growth segment.
  • Meiwu faces competition from established multinational and domestic brands like Winona, Pechoin, and Chando, which have longer operating histories, higher market shares, and established brand recognition. These competitors benefit from economies of scale, posing pricing challenges for Meiwu.
  • The gross margin for Meiwu's functional skincare products was 8.0% in 2025, which is significantly lower than the gross margins of its former food product categories (e.g., beverages, alcohol, and tea at 66.6% in 2024, or fresh fruits and vegetables at 81.0% in 2023). This suggests Meiwu is employing aggressive pricing strategies to gain market entry or faces higher initial costs compared to established players.
  • The Bitcoin industry is characterized by high volatility and regulatory uncertainty. Meiwu's plan to allocate up to 30% of its treasury to Bitcoin and hedge 50% of its holdings with futures contracts is a unique strategy for an operating company, contrasting with more traditional corporate treasury management practices. The recent approval of spot Bitcoin ETPs in the U.S. provides investors with direct exposure, potentially affecting the premium of companies like Meiwu that offer indirect exposure.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Co-Chief Executive OfficerQiulan LiNA2026-01-27Resigned due to personal reasons.
Chief Executive OfficerNAZhichao Yang2025-01-06New employment agreement.
Chief Financial OfficerNAZihao Liu2025-01-01New employment agreement.
Co-Chief Executive OfficerNAHandy Wijaya2026-01-20New employment agreement.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Policy AdoptionAdopted an Insider Trading Policy and Guidelines with Respect to Certain Transactions in the Company's Securities, effective July 1, 2024, amended April 15, 2026.2024-07-01Enhances compliance with insider trading laws and regulations, particularly with the new Section 16(a) reporting requirements for FPI directors and officers.
Policy AdoptionAdopted a compensation recovery policy required by Nasdaq Listing Rule 5608.NAAligns executive compensation practices with regulatory requirements, promoting accountability.
Committee FormationEstablished an Audit Committee, a Compensation Committee, and a Nominating and Corporate Governance Committee, each with a written charter.NAStrengthens corporate governance structure and oversight in key areas such as financial reporting, executive compensation, and board composition.
Board Diversity DisclosureDisclosed Board Diversity Matrix, showing 1 female and 4 male directors out of 5 total directors.NAIncreases transparency regarding board composition, aligning with evolving corporate governance best practices and stakeholder expectations.
Internal Control WeaknessIdentified a material weakness in internal control over financial reporting due to lack of in-house accounting personnel with sufficient US GAAP and SEC reporting experience.2025-12-31Indicates a risk of significant misstatements in financial statements if not remediated, potentially impacting investor confidence and regulatory compliance.

Legal Proceedings

  • Currently not a party to any legal or administrative proceedings that will likely have a material impact on business operations, financial condition, or results of operations.

Related Party Transactions

  • As of December 31, 2024, the company borrowed $1,291,608 as working capital from its chairman of the board, Changbin Xia. This loan was interest-free and due on demand, and was repaid on June 30, 2025.
  • During the years ended December 31, 2025, 2024, and 2023, the company purchased nil, nil, and $18,310 worth of food products from related parties, respectively.
  • As of December 31, 2025, 2024, and 2023, the account payable to related parties was nil, nil, and $15,627, respectively.
  • For the years ended December 31, 2025, 2024, and 2023, sales to related parties were nil, nil, and $21,215, respectively.

Stakeholder Impact

  • **Shareholders:** Face significant dilution from recent and planned capital raises and reverse stock splits. The substantial net loss in 2025 and low gross margin in the new core business could negatively impact share value. The Bitcoin treasury strategy introduces high volatility and regulatory risks, potentially affecting investment returns. The material weakness in internal controls over financial reporting also poses a risk to financial transparency and investor confidence.
  • **Employees:** The company has reorganized product and operations departments and recruited new employees for the functional skincare business, indicating job creation in this new segment. However, the termination of former VIE businesses likely resulted in job losses or reassignments in those areas. Share-based compensation plans (2022, 2024, 2025 Equity Incentive Plans) aim to attract and retain personnel.
  • **Customers:** The strategic pivot to functional skincare aims to offer new products and services, potentially benefiting customers seeking targeted dermatological solutions. The focus on quality control and training for distributors is intended to enhance customer experience. However, the delay in launching the AI-driven online ecosystem might impact customer access to integrated services.
  • **Suppliers:** The company relies on third-party manufacturers for skincare products and has significant advances to suppliers. Changes in supplier relationships or performance could impact product availability and quality. The shift in business focus means a change in demand for suppliers from former food and SMS businesses to new skincare-related suppliers.
  • **Creditors:** The company has engaged in significant capital raising activities, which could improve its financial stability and ability to meet obligations. However, the substantial net loss and asset impairment in 2025, along with the inherent volatility of the Bitcoin treasury strategy, could increase perceived credit risk.

Next Steps

  • Expand marketing, branding, and distribution network for functional skincare.
  • Purchase Bitcoin as part of treasury asset allocation, aiming for approximately 50% of 2026 Primary Offering net proceeds.
  • Pursue strategic acquisitions, including a potential downstream channel distributor.
  • Integrate AI-driven functional skincare system, with the online ecosystem launch rescheduled to Q3 2026.
  • Monitor PRC regulatory developments relating to cryptocurrency and adjust strategies accordingly.
  • Implement measures to remediate material weakness in internal control over financial reporting, including hiring outside financial personnel with US GAAP and SEC reporting experience.
  • Continue to develop new functional skincare formulas and products through partnerships with research institutions.
  • Establish a network of approximately 1,500 affiliate stores for functional skincare product distribution.

Key Dates

DateDescription
2015-06-16Meiwu Shenzhen incorporated in the PRC.
2018-12-04Meiwu Technology Company Limited incorporated in British Virgin Islands.
2018-12-28Guo Gang Tong (WFOE) incorporated in the PRC by Vande.
2019-02-15Meiwu acquired all shares of Vande.
2019-03-02WFOE entered into contractual agreements with Meiwu Shenzhen (VIE Agreements).
2019-08-19Company changed name from Advancement International Limited to Wunong Net Technology Company Limited.
2019-11-15Kindness Global Company Limited transferred 2,500 Ordinary Shares to Fragrance International Group Company Limited; Company issued 6,667 Ordinary Shares to Soaring International Company Limited and 3,333 Ordinary Shares to each of Morning Choice International Company Limited, August International Group Company Limited and Eternal Horizon International Company Limited.
2019-12-02Company filed amended memorandum and articles of association to change par value to no par value and forward split shares.
2020-09-29Meiwu Shenzhen, Huang, and Liu established Wude Agricultural Technology (Shanghai) Co., Ltd.
2020-10-20Meiwu Shenzhen entered into Equity Transfer Agreement to acquire 51% equity interests in Baode Supply Chain (Shenzhen) Co., Ltd.
2020-12-10Meiwu Shenzhen incorporated Wunong Technology (Shaanxi) Co., Ltd.
2020-12-15Meiwu Shenzhen transferred 51% ownership interest in Wude Shanghai to Huang and Liu; Company priced initial public offering.
2020-12-17Initial public offering closed; Ordinary Shares began trading on Nasdaq Capital Market.
2021-01-08Meiwu Shenzhen entered into Equity Transfer Agreement to acquire all equity interests in Wunong Technology (Liaoning) Co., Ltd.
2021-01-19Meiwu Shenzhen repurchased ownership interest in Baode.
2021-01-26Meiwu Shenzhen repurchased 100% ownership interest in Wunong Shaanxi.
2021-01-28Meiwu Shenzhen repurchased 51% ownership interest in Wude Shanghai.
2021-04-29Baode's registered capital increased to RMB 30 million.
2021-10-06Company changed name from Wunong Net Technology Company Limited to Meiwu Technology Company Limited.
2021-11-23Company entered into a Share Purchase Agreement with Boxinrui International Holdings Limited (Anxin BVI).
2021-12-28Meiwu Shenzhen sold 51% equity interests of Baode Supply Chain (Shenzhen) Co., Ltd to Mr. Shiliang Ma.
2022-03-31Company entered into a Share Purchase Agreement with Magnum International Holdings Limited (Yundian BVI).
2022-04-19Closing of Yundian SPA occurred.
2022-05-12Meiwu Shenzhen and Heme Consulting established Heme Brand Chain Management (Shenzhen) Co., Ltd.
2022-06-23Company entered into a Share Purchase Agreement with Mahaotiaodong Information Technology Company Limited (Mahao BVI); Closing of Mahao SPA occurred.
2022-07-22Heme Shenzhen established Heme Catering Management (Shenzhen) Co., Ltd.
2022-10-31Company changed name from Wunong Technology (Shenzhen) Co,. Ltd to Meiwu Zhishi Technology (Shenzhen) Co,. Ltd.
2022-12-12Company entered into a Share Purchase Agreement with Xinfuxin International Holdings Limited (Yuanxing BVI).
2022-12-23Closing of Yuanxing SPA occurred.
2023-05-04Meiwu Shenzhen, Kun Xu, and Senli Huinong established Shenzhen Jiayuan Liquor Sales Co., Ltd.
2023-11-27Shareholders approved a one-for-thirty-five share consolidation.
2023-12-01PIPL took effect.
2024-02-21Company issued 438,498 Ordinary Shares under incentive plan.
2024-05-17Company closed a securities purchase agreement for convertible notes (2024 Notes Offering).
2024-09-03Shenzhen Vande Technology Co., Limited incorporated Xiamen Chunshang Health Technology Co., Ltd.
2024-09-01PRC Data Security Law took effect.
2024-09-24Regulation on Network Data Security Management promulgated.
2024-10-23Company sold 30,000,000 Ordinary Shares to Mr. Changbin Xia.
2024-11-27Company entered into Primary Offering SPA and Registration Statement declared effective.
2024-12-02Company closed Primary Offering of 30,000,000 Ordinary Shares.
2024-12-10WFOE and Meiwu Zhishi (former VIE) terminated VIE Agreements.
2024-12-24Company entered into share transfer agreements for Magnum and Xinfuxin Disposition.
2024-12-31Magnum Disposition and Xinfuxin Disposition closed.
2025-01-01Xiamen Chunshang lease agreement for executive offices effective; Regulation on Network Data Security Management took effect.
2025-01-10SEC approved listing and trading of spot bitcoin ETPs.
2025-01-21SEC launched Crypto Task Force.
2025-01-23SEC rescinded Staff Accounting Bulletin 121 (SAB 121) by issuing new Staff Accounting Bulletin 122 (SAB 122); President Trump issued an executive order revoking prior administration's executive order and Treasury Department's framework, establishing the Presidential Working Group on Digital Asset Markets.
2025-02-20SEC announced the creation of the Cyber and Emerging Technologies Unit.
2025-03-05Shareholders approved a one-for-twenty share consolidation.
2025-03-06Xiamen Chunshang incorporated Guangzhou Tianhe District Chunran Health Consulting Co., Ltd.; President Trump signed an Executive Order to establish a Strategic Bitcoin Reserve and a United States Digital Asset Stockpile.
2025-04-012025 Reverse Split of Ordinary Shares on a one-for-twenty basis became effective; Ordinary Shares began trading on a 2025 Reverse Split-adjusted basis.
2025-05-09President Trump issued an executive order aimed at curbing the overuse of criminal penalties in federal regulatory laws.
2025-05-20Xiamen Chunshang entered into patents transfer agreement with Meixing Biotechnology Research Institute Co., Ltd.; SEC Chairman Paul Atkins testified before the House Appropriations Subcommittee on Financial Services and General Government.
2025-06-12SEC formally withdrew fourteen outstanding rule proposals.
2025-06-25Xiamen Chunshang entered into a functional skincare products research and development service agreement with Guangdong Daao Biotechnology Research Institute Co., Ltd.
2025-06-30Xiamen Chunshang entered into patents transfer agreement with Meixing Biotechnology Research Institute Co., Ltd.
2025-07-01Xiamen Zhongda Information Technology Co., Ltd. lease agreement for warehouse effective.
2025-07-17CLARITY Act passed by the House of Representatives.
2025-07-18Guiding and Establishing National Innovation for U.S. Stablecoins Act of 2025 (GENIUS Act) signed into law.
2025-07-30Presidents Working Group on Digital Asset Markets released a report.
2025-07-31SEC Chairman Atkins delivered a speech outlining Project Crypto.
2025-08-01SEC announced Crypto Task Force roundtables.
2025-08-07President Trump issued an executive order regarding 401(k) plans and alternative investments.
2025-08-11Company adopted the 2025 Equity Incentive Plan; Company issued 475,220 Ordinary Shares under incentive plan.
2025-09-05Mr. Xia purchased 12,000,000 restricted Ordinary Shares.
2025-09-10Transaction for Mr. Xia's purchase of 12,000,000 restricted Ordinary Shares closed.
2025-11-182026 Registration Statement initially filed with the Commission.
2025-11-01Target patents for skincare formulations transferred.
2026-01-01Cybersecurity Law last amendment became effective.
2026-01-222026 Registration Statement declared effective by the Commission.
2026-01-26Company entered into 2026 Primary Offering SPA.
2026-01-27Ms. Qiulan Li resigned as Co-Chief Executive Officer.
2026-01-292026 Primary Offering closed.
2026-03-17Company effectuated the 2026 Reverse Split of its Ordinary Shares on a one-for-one hundred basis; Directors, officers, and major shareholders entered into lock-up agreements.
2026-03-18Company entered into a securities purchase agreement for 6,999,996 Ordinary Shares and warrants; Offering closed.
2026-04-06Ordinary Shares began trading on a 2026 Reverse Split-adjusted basis.
2026-04-17Date of this annual report.

Recommendation

hold

The company is undergoing a significant strategic transformation, pivoting from underperforming legacy businesses to functional skincare and a Bitcoin treasury strategy. While the revenue growth in the new skincare segment is positive, the substantial net loss, low gross margin, and significant impairment charges in 2025 indicate considerable execution risk and a challenging path to profitability. The Bitcoin strategy introduces high volatility. Investors should hold to observe the successful implementation of the new business model, improvement in profitability metrics, and effective management of the inherent risks associated with both the new skincare venture and the volatile digital asset holdings before considering further investment.

Keywords

Functional Skincare, Bitcoin Treasury, SEC Filing, China Business, VIE Termination, Financial Results, Capital Raise, Reverse Stock Split, Corporate Governance, Risk Management, Cosmetics Industry, Digital Assets, PRC Regulation, NASDAQ

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.